Journals / Journal of Turkish Spinal Surgery / 2019 / Cilt: 30 - Sayı: 1

THE EFFECT OF THE USAGE OF CELL- SAVER AND TRANEXAMIC ACID ON THE AMOUNT OF INTRAOPERATIVE ALLOGENIC BLOOD TRANSFUSION WHILE MANAGING BLOOD LOSS IN ADOLESCENT IDIOPATHIC SCOLIOSIS SURGERY

Pages
13–16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Especially we think about that 10mg/kg bolus and 1mg/kg/ hour maintenance doses of tranexamic acid are effective and safe.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background Data: Reconstructive adolescent idiopathic scoliosis surgery performed by applying pedicle screw system with posterior approach is a major surgical procedure.
📊
Key Findings & Data:Materials and Methods: In our hospitals spine surgery clinic, between 2012 and 2018, a total of 58 patients whom met the inclusion criteria, were divided into 3 groups and these two methods (CS and TXA groups) were compared with the patients who underwent surgery without applying any blood loss reduction procedure.
💡
Conclusion & Impact:Especially we think about that 10mg/kg bolus and 1mg/kg/ hour maintenance doses of tranexamic acid are effective and safe.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

Background Data: Reconstructive adolescent idiopathic scoliosis surgery performed by applying pedicle screw system with posterior approach is a major surgical procedure. Allogenic blood transfusion is one of the oldest known method for volume loss during this surgery. In order to reduce the amount of intraoperative and postoperative blood transfusion, methods such as cell-saver (CS) and tranexamic acid (TXA) have been used. Our study was performed to assess the efficacy and safety of these two methods. Materials and Methods: In our hospitals spine surgery clinic, between 2012 and 2018, a total of 58 patients whom met the inclusion criteria, were divided into 3 groups and these two methods (CS and TXA groups) were compared with the patients who underwent surgery without applying any blood loss reduction procedure. Group 1 consisted of patients whom we applied cell-saver only (n: 19), group 2 consisted of patients whom we applied tranexamic acid only (n: 19) and group 3 consisted of the patients whom had undergone surgery without applying any other blood loss reduction procedure (n: 20). Gender, age, screwing levels, how many units allogenic blood transfusion were performed except than autogenic blood transfusion by CS during the operation were respectively determined in all three groups. Also complications related to blood loss reduction procedures intraoperatively and postoperatively were evaluated. Results: When all 3 groups were considered together, the statistical difference was significant in terms of the amount of blood transfusion (p.0). While there was no significant difference in the amount of blood transfusion between group 1 and group 2 (p.4), there was significantly less amount of blood transfusion between group 1 & group 3 and between group 2 & group 3 (p.0 and p.0, respectively). None of the patients had major or minor complications related with managing blood loss. Conclusions: The usage of cell-saver and/or tranexamic acid during reconstructive adolescent idiopathic scoliosis surgery significantly reduces the amount of intraoperative allogenic blood transfusion. Especially we think about that 10mg/kg bolus and 1mg/kg/ hour maintenance doses of tranexamic acid are effective and safe.

🔖

Cite This Article

KARGIN, D., TÜRK, Ö. İ., ASANSU, M. A., ÖNER, A., İLVAN, G., KAYGUSUZ, M. A. (2019). THE EFFECT OF THE USAGE OF CELL- SAVER AND TRANEXAMIC ACID ON THE AMOUNT OF INTRAOPERATIVE ALLOGENIC BLOOD TRANSFUSION WHILE MANAGING BLOOD LOSS IN ADOLESCENT IDIOPATHIC SCOLIOSIS SURGERY. Journal of Turkish Spinal Surgery, Cilt: 30 - Sayı: 1, 13–16. https://ajindex.com/articles/192853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Behrman MJ, Keim HA. Perioperative red blood cell salvage in spine surgery. A prospective analysis. Clin Orthop Relat Res 1992; 278: 51–57.
  2. Bowen RE, Gardner S, Scaduto AA, Eagan M, Beckstead J. Efficacy of intraoperative cell salvage systems in pediatric idiopathic scoliosis patients undergoing posterior spinal fusion with segmental spinal instrumentation. Spine 2010; 15; 35(2): 246–251.
  3. Charles A, Reitman M, William C, Watters MD, Walter R, Sassard MD The Cell Saver in adult lumbar fusion surgery. Spine 2004; 29(14): 1580–1584.
  4. Colomina MJ, Koo M, Basora M, Pizones J, Mora L, Bago J. Intraoperative tranexamic acid use in major spine surgery in adults: a multicentre, randomized, placebo-controlled trial. Br J Anaesth 2017; 118: 380-390.
  5. Gause PR, Siska PA, Westrick ER, Zavatsky J, Irrgang JJ, Kang JD. Efficacy of intraoperative cell saver in decreasing postoperative blood transfusions in instrumented posterior lumbar fusion patients. Spine 2008; 33(5): 571-575
  6. Glance L, Dick A, Mukamel D, Fleming F, Zollo R, Wissler R, Salloum R, Meredith UW, Osler TM. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing non-cardiac surgery. Anesthesiology 2011; 114: 283-292.
  7. Goulet JA, Bray TL, Timmerman LA, Benson DR, Bargar WL.Intraoperative autologous transfusion in orthopedic patients. J Bone Joint Surg 1989; 71-A(1): 3–8.
  8. Hui S, Xu D, Ren Z, Sheng L, Zhuang Q, Li S. Can tranexamic acid conserve blood and save operative time in spinal surgeries? A meta-analysis. Spine J 2018; 8: 1325-1337.
  9. Jones KE, Butler EK, Barrack T, Ledonio CT, Forte ML. Tranexamic acid reduced the percent of total blood volume lost during adolescent idiopathic scoliosis surgery. Int J Spine Surg 2017; 11: 27. Kolawole AJ, Aaron JB, Edward MD, Peter LZ, Zhou PL, Vasquez-Montes D, Goldstein JA, Bendo JA.The use of cell saver in spinal surgery: a value-based utilization analysis. Spine J 2017; 10: 201. Li Z-J, Fu X, Xing D, Zhang H-F, Zang J-C, Ma X-L. Is tranexamic acid effective and safe in spinal surgery? A meta- analysis of randomized controlled trials. Eur Spine J 2013; 22(9): 1950-1957.
  10. Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesthe Analg 2001; 93: 82–87.
  11. Regan F, Taylor C. Blood transfusion medicine. BMJ 2002; 325(7356): 143-147.
  12. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections.